Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association.

Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, Darouiche RO, Ramlawi B, Derdeyn CP, Bolger AF, Levison ME, Taubert KA, Baltimore RS, Baddour LM; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Peripheral Vascular Disease; and Stroke Council.

Circulation. 2016 Nov 15;134(20):e412-e460. Epub 2016 Oct 13. Review. No abstract available.

PMID:
27737955
2.

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council.

Circulation. 2015 Oct 13;132(15):1435-86. doi: 10.1161/CIR.0000000000000296. Epub 2015 Sep 15. Review. Erratum in: Circulation. 2015 Oct 27;132(17):e215. Circulation. 2016 Aug 23;134(8):e113. Circulation. 2018 Jul 31;138(5):e78-e79.

PMID:
26373316
3.

Diseases Transmitted by Birds.

Levison ME.

Microbiol Spectr. 2015 Aug;3(4). doi: 10.1128/microbiolspec.IOL5-0004-2015. Review.

PMID:
26350315
4.

Community-acquired culture-negative endocarditis: clinical characteristics and risk factors for mortality.

Siciliano RF, Mansur AJ, Castelli JB, Arias V, Grinberg M, Levison ME, Strabelli TM.

Int J Infect Dis. 2014 Aug;25:191-5. doi: 10.1016/j.ijid.2014.05.005. Epub 2014 Jun 25.

5.

Travel-related health risks. Part 3: non-mosquito-borne infectious illnesses.

Levison ME.

MD Advis. 2013 Spring;6(2):E37-43. No abstract available.

PMID:
24037439
6.

Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens.

Levison ME, Kaye D.

Curr Infect Dis Rep. 2013 Apr;15(2):109-15. doi: 10.1007/s11908-013-0315-7.

PMID:
23378123
7.

Travel-related health risks part 2: emerging mosquito-borne infectious illnesses.

Levison ME.

MD Advis. 2012 Fall;5(4):E41-5. Review. No abstract available.

PMID:
23132108
8.

Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.

Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, Wilson WR, Smith SC Jr, Baddour LM; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology.

Circulation. 2012 May 22;125(20):2520-44. doi: 10.1161/CIR.0b013e31825719f3. Epub 2012 Apr 18.

PMID:
22514251
9.

Travel-related health risks part 1: trauma and complications from underlying health problems.

Levison ME.

MD Advis. 2012 Winter;5(1):29-32. No abstract available.

PMID:
22318300
10.

A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care and Outcomes Research.

J Am Dent Assoc. 2011 Feb;142(2):159-65. Erratum in: J Am Dent Assoc. 2011 Apr;142(4):375-6.

PMID:
21282681
11.

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association.

Circulation. 2010 Jan 26;121(3):458-77. doi: 10.1161/CIRCULATIONAHA.109.192665. Epub 2010 Jan 4.

PMID:
20048212
12.

Pharmacokinetics and pharmacodynamics of antibacterial agents.

Levison ME, Levison JH.

Infect Dis Clin North Am. 2009 Dec;23(4):791-815, vii. doi: 10.1016/j.idc.2009.06.008. Review.

13.

The other tick-borne diseases in New Jersey: babesiosis and human granulocytic anaplasmosis.

Levison ME.

MD Advis. 2009 Spring;2(2):4-11. No abstract available.

PMID:
21912357
14.

Mycobacterium bovis: an underappreciated pathogen.

Levison ME.

Curr Infect Dis Rep. 2008 Nov;10(6):444-6. No abstract available.

PMID:
18945383
15.
16.

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America.

Circulation. 2005 Jun 14;111(23):e394-434. Erratum in: Circulation. 2005 Oct 11;112(15):2373. Circulation. 2007 Apr 17;115(15):e408. Circulation. 2007 Nov 20;116(21):e547. Circulation.2008 Sep 16;118(12):e497.

PMID:
15956145
17.

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Pediatrics. 2004 Dec;114(6):1708-33. Erratum in: Pediatrics. 2005 Apr;115(4):1118.

PMID:
15574639
18.

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics.

Circulation. 2004 Oct 26;110(17):2747-71.

PMID:
15505111
19.

Pharmacodynamics of antimicrobial drugs.

Levison ME.

Infect Dis Clin North Am. 2004 Sep;18(3):451-65, vii. Review.

PMID:
15308272
20.

Nonvalvular cardiovascular device-related infections.

Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA.

Clin Infect Dis. 2004 Apr 15;38(8):1128-30. Epub 2004 Apr 1. No abstract available.

PMID:
15095218
21.

Nonvalvular cardiovascular device-related infections.

Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA; AHA.

Circulation. 2003 Oct 21;108(16):2015-31. Review. No abstract available.

PMID:
14568887
22.

Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals.

Levison ME, Mailapur YV, Pradhan SK, Jacoby GA, Adams P, Emery CL, May PL, Pitsakis PG.

Clin Infect Dis. 2002 Dec 15;35(12):1551-4. Epub 2002 Dec 2.

PMID:
12471576
24.

Unique features of infective endocarditis in childhood.

Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA.

Pediatrics. 2002 May;109(5):931-43. No abstract available.

PMID:
11986458
25.

Unique features of infective endocarditis in childhood.

Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association Council on Cardiovascular Disease in the Young.

Circulation. 2002 Apr 30;105(17):2115-26. No abstract available.

PMID:
11980694
26.

Anaerobic pleuropulmonary infection.

Levison ME.

Curr Opin Infect Dis. 2001 Apr;14(2):187-91. Review.

PMID:
11979131
27.

Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.

Levison ME, Mallela S.

Curr Infect Dis Rep. 2000 Oct;2(5):417-423.

PMID:
11095886
28.

Lessons Learned from History on Mode of Transmission for Control of Pneumonic Plague.

Levison ME.

Curr Infect Dis Rep. 2000 Aug;2(4):269-271. No abstract available.

PMID:
11095865
29.

Infective Endocarditis: Current Guidelines on Prophylaxis.

Levison ME, Abrutyn E.

Curr Infect Dis Rep. 1999 Jun;1(2):119-125.

PMID:
11095776
30.

Safety precautions to limit exposure from plague-infected patients.

Levison ME.

JAMA. 2000 Oct 4;284(13):1648-9. No abstract available.

PMID:
11015788
31.

Collaborative multidisciplinary workshop report: detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae.

Tompkins LS, Schachter J, Boman J, Chernesky MA, Dowell S, Gaydos CA, Levison ME, Maass M, Madico G, Orfila J, Ouchi K, Peeling RW, Taylor-Robinson D, Stamm WE, Wang SP, Blasi F, Relman D.

J Infect Dis. 2000 Jun;181 Suppl 3:S460-1. No abstract available. Erratum in: J Infect Dis 2000 Nov;182(5):1581.

PMID:
10839740
32.

Cephalosporins, carbapenems, and monobactams.

Asbel LE, Levison ME.

Infect Dis Clin North Am. 2000 Jun;14(2):435-47, ix. Review.

PMID:
10829264
33.

Pharmacodynamics of antibacterial drugs.

Levison ME.

Infect Dis Clin North Am. 2000 Jun;14(2):281-91, vii. Review.

PMID:
10829256
34.

Risk factors for infective endocarditis: oral hygiene and nondental exposures.

Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D.

Circulation. 2000 Dec 5;102(23):2842-8.

PMID:
11104742
35.

Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study.

Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D.

Ann Intern Med. 1998 Nov 15;129(10):761-9.

PMID:
9841581
36.

Prevention of bacterial endocarditis: recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

Clin Infect Dis. 1997 Dec;25(6):1448-58.

PMID:
9431393
37.

Prevention of bacterial endocarditis: recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

J Am Dent Assoc. 1997 Aug;128(8):1142-51.

PMID:
9260427
38.

Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

Circulation. 1997 Jul 1;96(1):358-66. Review.

PMID:
9236458
39.

Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

JAMA. 1997 Jun 11;277(22):1794-801. Review.

PMID:
9178793
40.

An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis.

Sekeres MA, Abrutyn E, Berlin JA, Kaye D, Kinman JL, Korzeniowski OM, Levison ME, Feldman RS, Strom BL.

Clin Infect Dis. 1997 Jun;24(6):1185-90.

PMID:
9195080
41.

Peritonitis: update on pathophysiology, clinical manifestations, and management.

Johnson CC, Baldessarre J, Levison ME.

Clin Infect Dis. 1997 Jun;24(6):1035-45; quiz 1046-7. Review. No abstract available.

PMID:
9195055
42.

Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.

Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC.

Antimicrob Agents Chemother. 1996 Jun;40(6):1526-30.

43.

Incidence of infective endocarditis in the Delaware Valley, 1988-1990.

Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, Feldman RS, Kaye D.

Am J Cardiol. 1995 Nov 1;76(12):933-6.

PMID:
7484834
44.

Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects.

Levison ME.

Infect Dis Clin North Am. 1995 Sep;9(3):483-95. Review.

PMID:
7490429
45.

Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.

Johnson CC, Livornese L, Gold MJ, Pitsakis PG, Taylor S, Levison ME.

J Antimicrob Chemother. 1995 Jun;35(6):765-73.

PMID:
7559188
46.

In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.

Johnson CC, Slavoski L, Schwartz M, May P, Pitsakis PG, Shur AL, Levison ME.

Diagn Microbiol Infect Dis. 1995 Mar;21(3):169-73.

PMID:
7648837
47.

Assessing diagnostic criteria for active infective endocarditis.

Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, Feldman RS, Kaye D.

Am J Cardiol. 1994 May 1;73(12):887-91.

PMID:
8184814
48.

The bactericidal activity of magainins against Pseudomonas aeruginosa and Enterococcus faecium.

Levison ME, Pitsakis PG, May PL, Johnson CC.

J Antimicrob Chemother. 1993 Oct;32(4):577-85.

PMID:
8288499
49.

Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.

Whitman MS, Pitsakis PG, Zausner A, Livornese LL, Osborne AJ, Johnson CC, Levison ME.

Antimicrob Agents Chemother. 1993 Oct;37(10):2069-73.

50.

Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections.

Livornese LL, Gold M, Johnson CC, Measley R, Kaye D, Korzeniowski O, Walsh ML, Samel C, Hessen M, Levison ME.

J Antimicrob Chemother. 1993 Jan;31(1):188-91. No abstract available.

PMID:
8444670

Supplemental Content

Loading ...
Support Center